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Follicular helper T (Tfh) cells are the class of effector T helper cells that regulates the step-wise development
of antigen-specific B cell immunity in vivo. Deployment of CXCR5+ Tfh cells to B cell zones of lymphoid
tissues and stable cognate interactions with B cells are central to the delivery of antigen-specific Tfh cell
function. Here, we review recent advances that have helped to unravel distinctive elements of developmental
programming for Tfh cells and unique effector Tfh cell functions focused on antigen-primed B cells. Under-
standing the regulatory functions of Tfh cells in the germinal center and the subsequent regulation of memory
B cell responses to antigen recall represent the frontiers of this research area with the potential to alter funda-
mentally the design of future vaccines.Introduction
Clonal selection and the programmed development of antigen-
specific immune function are the central defining characteristics
of adaptive immunity. Classical studies identified the cells of the
immunesystemas the fundamental unit of clonal selection (Burnet,
1957; Talmage, 1957) and evidence for the production of anti-
bodies with single specificities by individual lymphocytes (Nossal,
1959) as the operative effector mechanism. At least two types of
lymphocytes comprised the responding cellular compartment,
with T cells enhancing the production of antibodies by B cells
(Claman et al., 1966; Miller and Mitchell, 1967). Early studies with
hapten-carrier conjugates (Mitchison, 1971; Paul et al., 1966)
postulated the existence of an antigen-bridge for T-B cooperation
(Rajewsky et al., 1969) and helped to establish the basic tenets of
‘‘cognate’’ help for antigen-specific B cell immunity.
It is now clear that antigen-specific T helper cell development
can proceed inmultiple directions depending on the nature of the
antigenic assault. The original Th1, Th2 paradigm (Mosmann and
Coffman, 1989) identified distinguishable T helper cell functional
programs based on differential cytokine production with distinct
cellular targets of action in vivo (Zhu and Paul, 2008). More
recently, multiple subsets of regulatory Th (Treg) cells have
been described as negative regulators of immune responsive-
ness to inhibit self-reactivity or guard against over-reactivity to
pathogens (Sakaguchi, 2004). The Th17 cell subset adds an
additional layer to this complex system of immune regulation,
identifying separable developmental programs and cytokine
profiles associated with extracellular bacteria and fungi, chronic
inflammatory disease, and autoimmunity (Korn et al., 2009).
There also exist less well-defined T helper cell subsets capable
of modifying DCmaturation in ways that impact the development
of effective CD8+ T cell memory. In this context, follicular helper
T (Tfh) cells can be considered a separable T helper cell subset
specialized to regulate the evolution of effector and memory
B cell responses (Fazilleau et al., 2007b; King et al., 2008;
Vinuesa et al., 2005b). How the Tfh cell compartment develops
in vivo and differs from other subsets of effector T helper cells
is the subject of the current review.324 Immunity 30, March 20, 2009 ª2009 Elsevier Inc.Recent evidence suggests that Tfh cells constitute a separate
lineage of effector T helper cells with distinct developmental
programming and distinguishable effector function. There is
also evidence to suggest that deployment of all effector Th cell
subsets to appropriate follicular locations defines a unique set
of effector Tfh cell functions. We will present both positions
and suggest that Th cell lineage differentiation and the program-
ming of follicular location define multiple subsets of effector Tfh
cells needed to regulate antigen-specific B cell immunity. The
regulation of antibody isotype across both effector and memory
B cell development is one heterogeneous facet of Tfh cell
function that will be discussed in more detail. Furthermore, the
distinction between pregerminal center (GC) effector Tfh and
GC Tfh cell function needs more clarity and is an important
area of current research that will be discussed below. Finally,
the maintenance and function of antigen-specific memory Tfh
cells that regulate memory B cell responses is an emerging
area of research that will be discussed in the last section of the
review.
Th Cell-Regulated B Cell Immunity
It is important to consider the temporal and spatial cellular
dynamics that accompany Th cell-regulated B cell immunity
(MacLennan, 1994;McHeyzer-Williams andMcHeyzer-Williams,
2005). Specific recognition of peptide MHCII (pMHCII)
complexes with threshold TCR affinity and adequate costimula-
tion (checkpoint I, Figure 1) controls antigen-specific Th clonal
selection, responder Th cell expansion, and effector Th cell
differentiation. Naive B cells will also encounter antigen in
draining LNs very early after initial antigen priming (Batista and
Harwood, 2009). Antigen-specific B cells will internalize antigen,
process and present pMHCII complexes, and move to the T-B
borders of LNs to receive help from pMHCII-specific Th cells
(checkpoint II, Figure 2; Allen et al., 2007a). Under the cognate
control of effector Th cells, antigen-specific B cell development
then divides into two major pathways, plasma cell (PC) versus
germinal center (GC) development. The spectrum of effector
Th cell activities delivered at this major developmental juncture
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This figure depicts the first contact between pMHCII+ DC and naive pMHCII-specific Th cells (referred to as checkpoint I). Intercellular cognate contact involves
TCR-pMHCII interactions in the context of a range of costimulatory that include CD80-CD86 andCD28 interactions. The extent and quality of costimulationwill be
controlled by the inflammatory context of antigen exposure for the DC at immunization. The cytokines produced by the activatedDC aswell as the initial cytokines
produced by the activated Th cells will regulate the Th cell lineage that develops after clonal selection, expansion, and differentiation in effector function. Some of
the major known influences to the developmental of separate Th cell lineages are depicted for comparison with what is currently understood about effector Tfh
cell development. The arc on the right depicts a time point after clonal expansion and effector Th cell differentiationwhen Th cells from all lineages either (1) remain
in the T cell areas of LNs or (2) migrate to the B cell areas or (3) leave the LNs to distal tissues and not return during the first week after priming. The migratory
division and cell surface phenotype are predictions based on our recent study with protein vaccination in an adjuvant containing a TLR-4 agonist and the use of an
FTY720 analog to block LN emigration after priming (Fazilleau et al., 2009).belongs to the pMHCII-specific effector Tfh cell compartment.
The GC supports somatic diversification of BCR and selection
of high-affinity variants into the memory B cell compartment
(MacLennan, 1994;McHeyzer-Williams andMcHeyzer-Williams,
2005). Follicular dendritic cells (FDC) present antigen to survey
variant BCR for effective antigen binding affinity (checkpoint
IIIA, Figure 3), whereas pMHCII-specific GC Tfh cells form stable
cognate conjugates with antigen-specific GCB cells (checkpoint
IIIB, Figure 3; Hauser et al., 2007b). The functions of pMHCII-
specific GC Tfh cells are fundamentally distinct from pre-GC
effector Tfh cells and thought to regulate clonal selection of
GC B cells and entry into the memory B cell compartment.
CXCR5+ Follicular Helper T Cells
As the name implies, the cardinal characteristic of all Tfh cells is
their repositioning into the follicular regions of secondary
lymphoid tissues. The chemokine receptor CXCR5 is highly
expressed on B cells and is largely responsible for B cell parti-
tioning into CXCL13-rich follicular areas in LNs (Ansel et al.,
2000; Forster et al., 1996). In contrast, naive T helper cells
express high amounts of CCR7, promoting extrafollicular place-
ment into CCL19- and CCL21-rich areas in lymphoid tissue(Forster et al., 1999). CXCR5 was first reported on T helper cells
as the expression of an orphan receptor BLR1 on a small
subpopulation of CD4+CD45RO+ resting memory phenotype
T helper cells (CD44hiCD62LloIL2Rlo) in the peripheral blood of
humans (Forster et al., 1994). Cells with this phenotype are
also greatly enriched in human tonsils and distributed in the
follicular areas and germinal centers (GC) of these inflamed
tissues (Forster et al., 1994). In vitro, costimulation of CD4+
T cells through OX-40 and CD28 also induced CXCR5 expres-
sion and IL-4 secretion (Flynn et al., 1998). Importantly, blocking
Th cell activation in vivo with CTLA4-Ig or in CD28-deficient
animals also blocked OX-40, CXCR5-expressing Th cells and
the development of germinal centers (Walker et al., 1999). At
the same time, rapid CXCR5 expression was demonstrated
directly on antigen-specific Th cells after priming in vivo (Ansel
et al., 1999). These antigen-specific CXCR5+ T helper cells
also lost CCL19 and 21 responsiveness and migrated to follic-
ular areas and GCs after priming. Hence, upregulation of
CXCR5 and downregulation of CCR7 help to increase the prob-
ability of antigen-specific contact between pMHCII-specific Th
cells and antigen-primed pMHCII+ B cells in draining lymphoid
tissue.Immunity 30, March 20, 2009 ª2009 Elsevier Inc. 325
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This figure depicts the molecular interactions known to be involved at the cellular interface upon first contact of an effector Tfh cell and an antigen-primed B cells.
Cell surface molecules are emphasized with the presence of IL-21 depicted as one of many cytokine exchanges that may ensue. On the left side of the figure, we
depict multiple Tfh cell subsets that would arise as Th cells of known lineages that adopt the developmental program of follicular placement. This program is
largely defined as the loss of CCR7 and expression of CXCR5 but relies on appropriate positioning in the follicular regions and subsequent contact with an
antigen-primed B cell. On the right side of the figure, we depict the two major outcomes for B cells after receipt of antigen-specific T cell help: (1) entry into
the extrafollicular short-lived PC pathway to terminal differentiation or (2) movement into the follicular areas to rapidly expand and form the GC in the pathway
to memory B cell development. Isotype switch proceeds in both pathways controlled by the cytokine mixture and cell contact received at this critical second
developmental checkpoint.Tfh Cell Function
In these earliest reports of Tfh cells, B helper cell function was
assessed with CXCR5+ Th cells from human tonsils (Breitfeld
et al., 2000; Schaerli et al., 2000). The CXCR5+ Th cell compart-
ment contained all the capacity to support IgG and IgA produc-
tion when cocultured with B cells from the same tonsils. Func-
tional assessment of cytokine production by in vitro
restimulated CXCR5+ Th cells from human peripheral blood indi-
cated some IL-2, IFN-g, and IL-10 production with negligible
Th2 cytokines IL4, IL-5, or IL-13 (Schaerli et al., 2000).
Antigen-specific TCR transgenic transfer experiments first
demonstrated the concurrent and divergent development of
tissue homing versus antibody promoting effector Th cells
(Campbell et al., 2001). In contrast to the tissue-homing Th cells,
the B cell helper subset was responsive to CXCL13 and not
CCL21 with higher amounts of IFN-g and IL-4 upon restimulation
in vitro. Both effector Th cell subsets expressed similar amounts
of ICOS and CD40L, indicating the presence of shared effector
potential (Campbell et al., 2001). Hence, CXCR5hiCCR7lo
antigen-primed Th cells define a distinguishable subset of Th
cells now called follicular B helper T cells or, more commonly,
follicular helper T cells.
Tfh Cells as a Separate Th Cell Lineage
The range of effector functions associated with Th cells is exten-
sive and the organization and developmental programming of
these functions remains a focus of intense research. Changes
in costimulation and cytokine delivery upon first contact with
pMHCII-expressing DC have a major impact on Th cell fate
and function (depicted in Figure 1). Manipulating these signals326 Immunity 30, March 20, 2009 ª2009 Elsevier Inc.in vitro and in vivo have provided important insights into the deri-
vation of different effector Th cell lineages and is the basis for
most studies on Th cell lineage development (Zhu and Paul,
2008). Antigen-specific naive Th cells use initial instructive
signals to drive cell-intrinsic developmental programs in their
clonal progeny to define separable effector Th cell lineages.
Th1 versus Th2 Cells
The original Th1-Th2 paradigm identified differential programs of
cytokine production thought to regulate cell-mediated immunity
versus the production of antibody by B cells (Mosmann andCoff-
man, 1989). Th1 cells mediate immune responses to intracellular
pathogens (Paul and Seder, 1994). IL-12 and IFN-g are the
principle inducers of the Th1 program with a synergistic role
for IL-18. Induction of IL-12Rb2 upon TCR activation increases
Stat4-dependent IL-12 responsiveness in this pathway. Stat1-
dependent IFN-g signals induce the Th1 master regulator
T-bet that not only induces further IFN-g production but also
inhibits IL-4 expression (Szabo et al., 2003). In contrast, Th2 cells
mediate immune responses to extracellular parasites through
the production of IL-4, IL-5, IL-13, and IL-25. Amplification of
the Th2 program occurs through expression of IL-4R and Stat6
transduction of IL-4 signals that lead to the expression of the
Th2 master regulator GATA-3 (Kaplan et al., 1996; Zheng and
Flavell, 1997). GATA-3 is required for Th2 differentiation but
also blocks the Th1 program. IL-2 can also potentiate Th2 cyto-
kine production in a Stat5a-dependent mechanism (Zhu et al.,
2003). In this manner, Th1 and Th2 can be considered alternate
and nonoverlapping cell fates that define separate Th cell line-
ages with each program also extinguishing the alternate cell fate.
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The left side of this figure depicts the molecular interactions associated with continuous movement of variant GC B cells along the stromal network of mature
FDC that have coated immune complexes on their dense light zone processes through FcR and complement receptors. The right side of the figure depicts
the intercellular engagement of a GC Tfh cell and a GC B cell. We have not labeled the molecules because there is still very little information on the molecular
nature of this interaction regarding cell surface molecules or secreted cytokines. The phenotype that has been reported is largely similar between effector Tfh
cells and their GC Tfh cell counterparts. The far right of figure depicts the predicted cellular outcomes of checkpoints IIIA and IIIB interactions based on the known
output of the GC reaction. There are broadly two classes of memory B cell that exit the GC: (1) high-affinity precursors for the memory response to antigen
rechallenge that exist in a variety of physiological states and (2) long-lived PCs that contribute high-affinity antibodies to the circulation of the animal largely
for life. The latter compartment is not considered able to react to antigen rechallenge but is nevertheless considered a component of long-term B cell immunity.
Finally, each post-GC pathway potentially comprises of all antibody isotypes that we proposemay be considered to be separable lineages of memory B cells. For
example, it is likely that IgG1 memory B cells have diverged in development from IgAmemory B cells and not only received distinct inducing signals to develop in
the first place (at checkpoint II) but reside in separable microenvironmental niches around the body with distinguishable migratory phenotype and also require
unique activation requirements upon antigen rechallenge.Th17 versus Treg Cells
More recently, a separable Th17 cell lineage has been
described (Harrington et al., 2005; Park et al., 2005). Th17 cells
were initially associated with autoimmune disease and chronic
inflammation but have also been shown to mediate responses
to extracellular bacteria and fungi through the production of
IL17A, IL-17F, and IL-22 (Korn et al., 2009). TGF-b and IL-6
were shown to induce IL-17 production from naive Th
cells (Bettelli et al., 2006; Veldhoen et al., 2006). Importantly,
TGF-b alone promoted Treg cell differentiation whereas addi-
tion of IL-6 not only induced high amounts of IL-17 but also
blocked the Foxp3-dependent development of Treg cells. Addi-
tion of IL-6 promoted expression of the orphan nuclear
receptor RORgt in a Stat3-dependent manner. RORgt was
necessary for Th17 development (Ivanov et al., 2006) with
a role for IRF-4 and IRF4-binding protein (Chen et al., 2008)
in the control of its expression. RORgt and the related RORa
can bind FoxP3 and antagonize its function as one means for
the reciprocal regulation of these two cell fates (Yang et al.,
2008; Zhou et al., 2008). IL-6 also induces IL23R to promote
survival and maintenance of Th17 cell function in the presence
of the innate cytokine IL-23 (Zhou et al., 2007). Hence, Th17
and Treg cells constitute separate lineages of Th cells with
unique transcriptional programs of development and distinct
sets of effector cytokines from each other and the original
Th1 versus Th2 options.Tfh Cells
IL-21 is an interesting additional member of the IL-2 family of
cytokines that plays an important role in Th cell lineage develop-
ment (Parrish-Novak et al., 2000; Spolski and Leonard, 2008).
Th17 cells, Tfh cells, and Th2 cells are all known to produce
IL-21. In Th17 cell development, IL-6 is a strong inducer of
IL-21 in a Stat3-dependent mechanism (Nurieva et al., 2007;
Zhou et al., 2007). Both IL-21- and IL21R-deficient animals are
defective in Th17 cell development, suggesting an autocrine
loop for Th17 cells with potential to amplify this particular lineage
decision (Korn et al., 2007; Nurieva et al., 2007). IL-21 and IL-21R
deficiency also impacts the development of B cell immunity with
impaired isotype switch and deficient GC development (Ozaki
et al., 2002; Spolski and Leonard, 2008). In this context, Tfh cells
are known to produce abundant amounts of IL-21 (Nurieva et al.,
2008; Vogelzang et al., 2008) creating potential autocrine action
with concomitant expression of IL21R (Chtanova et al., 2004;
Rasheed et al., 2006; Vinuesa et al., 2005a). Importantly,
IL-21R expression only on Th cells partially rescued the B cell
defect in IL21R-deficient animals (Vogelzang et al., 2008). These
studies also demonstrate a role for IL-21 in the development of
CXCR5+ICOShi Tfh cells that was further enhanced by contact
with ICOSL on B cells in vitro (Vogelzang et al., 2008) and
in vivo (Nurieva et al., 2008). At the same time, IL-6 was also
shown to induce IL-21 in Tfh cells in a Stat3-dependent manner
(Nurieva et al., 2008). TGF-bwas not required for effector Tfh cellImmunity 30, March 20, 2009 ª2009 Elsevier Inc. 327
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for Tfh cell development in vivo (Nurieva et al., 2008). Together,
these studies provide strong evidence for the differential
programming events that control Th17 cell and Tfh cell develop-
ment into separable Th cell lineages.
Earlier microarray analyses of Tfh cells also indicated sepa-
rable gene expression programs for the Tfh cell compartment.
An inital studywithCD57 andCXCR5expression to select human
tonsillar GC Tfh cells (Kim et al., 2001) emphasized high amounts
of the chemokine CXCL13 as a major attribute of Tfh cells (Kim
et al., 2004). In a separate study that compared CD57+ and
CD57CXCR5+ tonsillar T cells to Th1 and Th2 cells polarized
from cord blood in vitro and with central and effector memory
Th cells from human peripheral blood highlighted ICOS and
IL-21 as an abundant and unique product of CD57+ Tfh cells
(Chtanova et al., 2004). The SLAM family member CD84
(Schwartzberg et al., 2009) and CD200 were highlighted as pref-
erentially expressed by the Tfh cell compartment with evidence
for the differential expression of the transcriptional repressor
Bcl-6 (King et al., 2008; Vinuesa et al., 2005b). The use of CD57
was later called into question by a separate study that indicated
CXCR5hiICOShi cells had the greatest B cell helper activity in the
human tonsil (Rasheed et al., 2006). Nevertheless, this latter
study also highlighted CXCL13 expression, IL21 and IL21R
expression, as well as low amounts of GATA3 as distinctive in
Tfh cells (Rasheed et al., 2006). This study implicated TH2-asso-
ciated transcription factors suchas c-maf as being involved in Tfh
cell programming. Inmouse, gene expression studies of Tfh cells
associated with overexpression of ICOS also identified IL-21 and
CD200 as preferentially abundant in Tfh cells (Vinuesa et al.,
2005a) with Tfh gene expression clustering distinctly when
compared to Th1, Th2, and Th17 cells (Nurieva et al., 2008).
These expression studies strongly support the existence of
a unique developmental program that leads to effector Tfh cell
functions separable from the other known Th cell subsets.
Tfh Cell Location as a Developmental Program
Although the recent data on separable lineage development
are compelling, there are exceptions to the notion of a separate
Th cell lineage for the Tfh cell compartment. Both Th1 and Th2
cytokines are known to regulate antibody class switch
(McHeyzer-Williams and McHeyzer-Williams, 2005; Vinuesa
et al., 2005b) with IL-4 and IFN-g being the earliest examples
inducing IgG1 and IgE, and IgG2a, respectively (Snapper and
Paul, 1987). TGF-b and IL-10 are implicated in the switch to
IgA (Cazac and Roes, 2000; Dullaers et al., 2009), although the
cellular source of these factors during an immune response
has not been well described. In vitro polarized Th1 and Th2 cells
can both support B cell responses upon adoptive transfer.
Furthermore, both Th1 and Th2 cells primed in vivo can enter
follicular areas and interact with antigen-specific B cells (Pape
et al., 2003; Toellner et al., 1998). IL-17 has also been implicated
in the induction of autoreactive antibody responses. A recent
study localized IL-17-producing Th cells to the spontaneous
and exaggerated splenic GC responses of BXD2 autoimmune
prone mice, implicating the Th17 cells in the regulation of auto-
antibody (Hsu et al., 2008). Further to this notion, IL-17 produc-
tion was induced preferentially from CXCR5+ICOShi Tfh cells
after MOG peptide in CFA immunization (Bauquet et al., 2008).328 Immunity 30, March 20, 2009 ª2009 Elsevier Inc.ICOS-regulated IL-21 production through c-Maf was implicated
in this pathway to IL-17 production. These data contrast the lack
of IL-17 production from TCR transgenic Th cells exposed to
protein antigen in CFA (Nurieva et al., 2008) and may reflect
the inherent plasticity in Tfh cell programming or the impact of
antigen specificity and TCR signal strength in this process.
Finally, CD25+ Treg cells have been reportedwithin GC of human
tonsils that interfere with T cell help and the induction of anti-
body. There are also reports of direct suppression of antibody
production by FoxP3+ GC Treg cells (Lim et al., 2005). Thus, all
known Th cell lineages have the potential to migrate to follicular
areas and into the GC to participate in the regulation of B cell
immunity.
Polyclonal Antigen-Specific Tfh Cells
Directly monitoring antigen-specific Th cells in polyclonal
immune systems (McHeyzer-Williams and Davis, 1995) and the
advent of pMHCII tetramer technology (Altman et al., 1996)
provides experimental access to the polyclonal immune system.
These new technologies allow direct assessment of antigen-
specific Th cell responses to model antigens (Rees et al., 1999;
Savage et al., 1999), infectious disease (Malherbe et al., 2000;
Stetson et al., 2002), and local antigen persistence (McLachlan
et al., 2009). Our early studies with these strategies allowed
access to antigen-specific Th cell repertoire (Fazilleau et al.,
2007a; Malherbe et al., 2000, 2004, 2008; McHeyzer-Williams
et al., 1999), TCR responsiveness (Bikah et al., 2000), and
effector Th cell function in vivo (Panus et al., 2000).
Our recent studies focused on the local development of
antigen-specific CXCR5+CD44hiCD62Llo effector Tfh cells in the
draining LNs (Fazilleau et al., 2007a). By examining the mecha-
nism underlying this assortment of effector Th cell function, we
demonstrated that the strength of TCR-pMHCII binding influ-
enced themigratory behavior of antigen-specific effector Th cells
(Fazilleau et al., 2009). The highest pMHCII-binding TCR corre-
lated with the differentiation of effector Tfh cells and localization
to the B cell areas (CXCR5+CCR7lo). Under the same priming
conditions, intermediate pMHCII binding promoted emigrant
Th cells (CCR7loCD62Llo) that left the LN, and lowpMHCII binding
promoted T zone localized Th cells (CCR7hiCD62Lhi) (depicted in
Figure 1). In this polyclonal model, IL-2, IFN-g, IL-10, and T-bet
were expressed at equivalent degrees by all subsets of
pMHCII-specific effector Th cells at day 7 after priming. Cyto-
kines more typically associated with Tfh cells, IL-4 and IL-21,
were present in all Th cell subsets but at higher amounts in the
Tfh cell compartment. OX-40, CD69, and Bcl-6 were uniquely
present in the effector Tfh cell compartment. Hence, there was
evidence for multiple subtypes of Th cells with separable devel-
opmental programsassociatedwith thepMHCII-specific effector
Tfh cell compartment in this model system.
Therefore, deployment of separable Th cell lineages to follic-
ular regions may represent an overriding secondary develop-
mental program for the antigen-specific regulation of distinct
B cell fates. In this context, the nature of the innate stimulus
would dictate the balance of effector Th cell subsets and a subset
of these responders can relocate to the follicular regions to
regulate effector and memory B cell functions. For example,
CXCR5+CCR7lo IFN-g-producing, T-bet-expressing pMHCII-
specific Th1 cells could be considered to be a Tfh1 subtype of
Immunity
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(Figure 2) in vivo.
Pregerminal Center Effector Tfh Cells
Pre-GC effector Tfh cell function is delivered in an antigen-
specific manner to pMHCII-expressing B cells but how these
differential functions develop in vivo remains poorly resolved.
Under static conditions in vitro, successful pMHCII-TCR interac-
tions involve the ordered formation of a stable immunological
synapse (Bromley et al., 2001; Monks et al., 1998). Intercellular
adhesion facilitates the scanning for adequate TCR-pMHCII
interactions, central clustering, and rearrangement of the cellular
interface into a stable synapse (Bromley et al., 2001; Monks
et al., 1998). Real-time imaging with two-photon laser scanning
technology has provided outstanding clarity to these early
cellular interactions in vivo (Miller et al., 2002). Studies labeling
antigen-primed DC and pMHCII-specific Th cells indicate an
early phase of transient 5–10 min contacts followed by longer
duration interactions lasting many hours. Altered cell motility
promotes serial DC engagement that leads to cell clustering
and swarming behavior. The duration of DC-T cell contact during
this later phase impacts cell fate (Celli et al., 2007) with at least
6 hr of contact required to induce clonal expansion in CD4+ Th
cells. Nevertheless, the impact of these early events on the
development of effector and memory Th cell functions is less
clear and remains an important focus of current research.
Effector Tfh Cell Contact Duration
First contact between antigen-specific Th cell and antigen-
primed B cells has also been captured through dynamic imaging
(Okada et al., 2005). Stable ‘‘monogamous’’ interactions
between one antigen-specific Th cell and one B cell can last for
10–60minduration in the follicular regionsof theLNs. These inter-
actions were accompanied by highly dynamic movements, with
the B cells migrating extensively and leading the Th cells (Okada
et al., 2005). A more recent study demonstrated that expression
of the adaptor molecule SAP was needed to form long-duration
contacts with antigen-primed B cells (Qi et al., 2008). There
was no role for SAP in early Th cell-DC contacts, and the SAP-
deficient Th cells reached the follicular regions and expressed
all the hallmarks of effector Tfh cells (CXCR5+, CD40L+, ICOS+,
and OX40+) (Qi et al., 2008). However, in the absence of SAP,
Tfh cells were still capable of cytokine production (Cannons
et al., 2006) but unable to promote GC formation (Crotty et al.,
2003; Schwartzberg et al., 2009). Importantly, effective contact
duration between pre-GC effector Tfh cells and pre-GC B cells
promoted the entry of Tfh cells into the GC reaction (Qi et al.,
2008). Cognate interactions were also required for effective
contact duration and would not occur if the Th cell antigen and
the B cell antigen were unlinked (Qi et al., 2008). These studies
clearly establish that durationof pre-GCpMHCII-specific effector
Tfh cell contact with pre-GC B cells is needed to promote normal
GC formation. Furthermore, pre-GC effector Tfh cell contact with
pMHCII-expressing antigen-primed B cells may also be required
for aspects of GC Tfh cell functional development.
Effector Tfh Cell Function
Although location and cognate contact are important, it is
important to consider in more detail the driving forces andconsequences of checkpoint II interactions (Figure 2). Antigen-
activated B cells upregulate CCR7 while retaining CXCR5
expression to counterbalance migration to the T-B borders
(Reif et al., 2002). CXCR5+ effector Tfh cells must lose CCR7
expression to achieve follicular placement. Further, CXCR5
expression on Th cells is not required for follicular placement,
but aspects of Tfh cell activity such as isotype switch and GC
formation are decreased in its absence (Arnold et al., 2007; Hay-
nes et al., 2007). Increased CXCL13 expression by effector Tfh
cellsmay serve to attract CXCR5+ B cells (Kim et al., 2004). There
is also evidence for IL-21 producing extrafollicular Th cell activity
that controls self-reactive IgG production and is associated with
CXCR4 expression and the loss of P-selectin ligand 1 binding
(PSGL-1) (Odegard et al., 2008). Hence, B cell helper function
may not only reside in the follicular areas but with pMHCII-
specific Th cells that balance chemokine receptor expression
for appropriate placement in vivo.
Modifying Cognate Interactions
Cognate contact between effector Tfh cells and pMHCII-
expressing B cells defines a critical initiating event in the devel-
opment of effective B cell immunity that may be modified by
a multitude of cell surface-expressed molecules (depicted in
Figure 2). CD28 deficiency or treatment with blocking CD28
antibodies leads to profound defects in B cell immunity (Shahi-
nian et al., 1993). CD28 is required early to initiate naive Th cell
responsiveness to pMHCII+ CD80- and CD86-expressing DC.
In contrast, CD40-CD40L interactions are central to the delivery
of T cell help to B cells (Armitage et al., 1992). Mice and humans
deficient in CD40 or CD40L are unable to efficiently class switch,
form GCs, or promote memory B cell responses (Kawabe et al.,
1994; Xu et al., 1994). Interfering with OX40-OX40L interactions
prevents Tfh cell accumulation in follicular regions of LNs, sug-
gesting that early engagement with OX40L on activated DC or
on a CD3CD4+ accessory cell population (Kim et al., 2003)
was needed to facilitate appropriate Tfh cell migration. The
continued expression of OX40 on effector Tfh cells (Fazilleau
et al., 2009; Qi et al., 2008) also suggests a role in the modulation
of cell fate at effector Tfh cell-B cell interactions that may extend
to within the GC reaction. There are reports of other surface
molecules such as CD30 (Kim et al., 2003) and BTLA (Nurieva
et al., 2008) playing a role in the development of Tfh cells and
the delivery of Tfh cell functions in vivo.
The CD28 family member ICOS (Hutloff et al., 1999) has been
implicated in Tfh cell function in pre-GC and the GC interactions
with pMHCII-expressing B cells (Fazilleau et al., 2007b; King
et al., 2008; Vinuesa et al., 2005b). ICOS-deficient humans and
mice (Dong et al., 2001; McAdam et al., 2001; Tafuri et al.,
2001) and ICOS-L-deficient mice have marked deficits in anti-
body production, isotype switch, and GC formation. ICOS defi-
ciency is associated with decreased Tfh cell development and
ICOS is considered an important molecule in the delivery of
effector Tfh cell function (Nurieva et al., 2008; Vogelzang et al.,
2008). The highest amounts of ICOS are expressed on GC Tfh
cells with the greatest capacity to support antibody production
in vitro (Rasheed et al., 2006). Conversely, overexpression of
ICOS in mice with a regulatory defect in ICOS expression (Yu
et al., 2007) resulted in an overproduction of CXCR5+ Tfh cells
and in exuberant GC reactions with breakthrough autoimmuneImmunity 30, March 20, 2009 ª2009 Elsevier Inc. 329
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Reviewdisease (Vinuesa et al., 2005a). Recent studies indicate that
ICOS can substitute for CD28 and rescue the Tfh cell defects
and B cell defects in CD28-deficient mice (Linterman et al.,
2009a). Furthermore, the abundant CXCR5+ Tfh cells in this
model act in a T cell-autonomous manner to promote autoanti-
body production (Linterman et al., 2009b). Another CD28 family
member, PD-1, that has been implicated in the negative regula-
tion of chronically activated T cells has also been demonstrated
on GC Tfh cells in human tonsil and mouse (Haynes et al., 2007).
Positive and negative influences of costimulation are balanced in
ways that remain poorly understood in vivo.
Overall, the precise function of different costimulatory mole-
cules and their combinatorial impact on antigen-specific B cell
fate remains an exciting area of current interest. Quantitative
differences in cell surface molecules in combination with
mixtures of cytokines will likely synergize in predetermined
ways to skewpMHCII-expressing B cells into separate pathways
of B cell immunity. Unraveling these molecular combinations will
help to define the rules of molecular control for antigen-specific
B cell immunity.
PC versus GC Development
Effectively regulated pMHCII-expressing B cells will enter either
the PC or GC pathway at checkpoint II (Figure 2) in development.
The signaling lymphocyte activation molecule (SLAM) family of
molecules plays an important role at the effector Tfh cell-B inter-
face revealed through the action of the signal transducer SAP
(Schwartzberg et al., 2009). Adoptive transfer studies indicate
that the SAP defect in B cell immune responsiveness is primarily
a T cell defect (Veillette et al., 2008). When effective duration Tfh
cell-B contact cannot be sustained (Qi et al., 2008), the GC
reaction and memory B cell development is compromised. In
contrast, the extrafollicular pathway to plasma cell development
remains intact in the SAP-deficient animals with evidence for
acute antibody responses and isotype switch (Crotty et al.,
2003). SAP-deficient Th cells reconstituted with a Fyn-recruiting
mutant of SAP can promote cytokine production but still do not
support GC formation (Cannons et al., 2006). Taken together,
these data suggest that different subsets of effector Tfh cells
may regulate entry into the extrafollicular pathway to short-lived
PCs versus the GC pathway to memory B cell development.
Alternatively, these separate developmental ‘‘decisions’’ may
require separable signals from the same cohort of effector Tfh
cells (such as distinct affinity TCR-pMHCII interactions). Under-
standing and controlling the balance of early antibody responses
versus affinity-matured memory B cell responses may provide
useful and separate means for modifying the adaptive immune
response in future immunotherapeutic strategies.
Antibody Class Switch
Developmental progression in antigen-specific PCs and GC
B cells both involve the switch to downstream antibody isotypes
(McHeyzer-Williams and McHeyzer-Williams, 2005) (depicted in
Figure 2). Early studies indicated that switch occurred in extra-
follicular sites and within the GC at the same time (Jacob
et al., 1991). Thus, it is possible that some systemic factor
controlled these events in a coordinated way. Alternatively,
pMHCII-specific Tfh cells within both environments may actively
and simultaneously instruct these developmental outcomes. It is330 Immunity 30, March 20, 2009 ª2009 Elsevier Inc.also plausible that first contact with effector Tfh cells induces the
commitment to switch to a particular antibody isotype in
antigen-primed B cells, a process that requires multiple cell
divisions to complete (Tangye et al., 2003). In the latter model,
commitment to isotype switch would be imprinted by the
cytokine signals delivered in a cognate manner at first contact
with effector Tfh cells. As a corollary of this model, commitment
to a particular antibody isotype may also define a separable
lineage of antigen-experienced B cells with distinct origins and
requirements for survival, function, and long-term propagation
in vivo.
Based onwhat is understood about the cytokine control of iso-
type switch, there is evidence for the existence of multiple
effector Tfh cell subsets (depicted in Figure 2). CXCR5+ Th1 cells
that produce primarily IFN-gwould promote IgG2a production in
the progeny of contacted antigen-specific B cells. We could
consider this follicular homing subset, Tfh1 cells. In the same
manner, Tfh2 cells would produce primarily IL-4 and promote
switch to IgG1 and IgE in the clonal progeny of the primed B cells
(Snapper and Paul, 1987). Antigen-specific inducible Treg
cells producing TGF-b and IL-10 could direct IgA switch as
Tfh10 cells (Cazac and Roes, 2000; Dullaers et al., 2009). There
has also been a recent report of a TGF-b-producing Tfh cell
compartment that promotes not only IgA switch but also plasma
cell migration to mucosal tissue by upregulating CCR10 expres-
sion (Dullaers et al., 2009). IL-21 is another important secreted
factor in the regulation and/or enhancement of antibody isotype
switch (Spolski and Leonard, 2008). The absence of IL-21 alone
reduced IgG1 production with elevated IgE, whereas IL-4 and
IL-21 doubly-deficient mice display decreases in all antibodies
in the serum (Ozaki et al., 2002). Hence, pMHCII-specific effector
Tfh cells may direct antibody isotype commitment through
cognate and noncognate contact modified by the cytokine
combinations they deliver.
Bcl-6 and Blimp-1
Identifying antagonizing transcription factors allowed a more
detailed molecular analysis of Th cell lineage commitment. In
the Tfh cell arena, the transcriptional repressor Bcl-6 has been
used to distinguish the Tfh cell compartment from other Th cell
subsets as discussed above (Chtanova et al., 2004; Fazilleau
et al., 2009; Nurieva et al., 2008; Vinuesa et al., 2005b; Vogelzang
et al., 2008). This transcriptional repressor is highly expressed in
GC B cells and has been demonstrated in a fraction of GC Tfh
cells. Bcl-6-deficient mice have defective B cell responses with
an absence of GC and memory development (Dent et al.,
1997). In our recent analysis of Tfh cell development to protein
vaccination, we reported the expression of Blimp-1 in the
CCR7hiCXCR5lo T zone resident effector Th cell compartment
(Fazilleau et al., 2009). Blimp-1 was first described as a master
regulator for plasma cells but has now found roles in natural
Treg cell development (Kallies et al., 2006; Martins et al.,
2006), the differentiation of Th1 cells. Interestingly, these Bcl-6
and Blimp-1 are known to cross block (Martins and Calame,
2008), providing a means to extinguish the alternate cell fate in
a feedback regulatory manner. This pair of transcription factors
may represent antagonizing control of LN effector functions
and used to balance the T zone versus B zone effector Th cells
that emerge in response to antigenic assault.
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It must be emphasized that defects in either the priming of naive
Th cells and B cells or the ineffective cognate interactions at the
first contact between these two facets of the adaptive immune
systemwill result in GC defects. Hence, the lack of GC formation
is an unreliable phenotype for unraveling the impact of GC inter-
actions themselves. Nevertheless, the GC functions of Tfh cells
remain of intense interest and central importance to the under-
standing of high-affinity antigen-specific memory B cell genera-
tion (depicted in Figure 3).
The T cells within GC are predominantly CD4+ and reside
mainly in the light zones (Bowen et al., 1991; MacLennan,
1994). Antigen-specific Th cells have been shown to enter the
GC in adoptive transfer models (Garside et al., 1998) and during
the course of an immune response in polyclonal systems
(Gulbranson-Judge and MacLennan, 1996; Zheng et al., 1996).
Our early studies in protein vaccination noted the dynamics of
movement between pre-GC follicular regions at day 7 to
predominantly GC by day 9 after priming (McHeyzer-Williams
et al., 1999). This sequential positioning of antigen-specific Th
cells was also found within the spleen of the polyclonal
responders (Gulbranson-Judge and MacLennan, 1996).
However, not all antigen-specific Th cells entered the GC with
evidence for particular sets of the responsive TCR repertoire
not assorting into the GC (Mikszta et al., 1999). Importantly,
these studies also monitored memory development for addi-
tional non-GC clonotypes to demonstrate that GC entry was
not required for memory Th cell development. Static analysis
of GC Th cell in situ suggested that GCswere open environments
for Th cells with evidence from microdissection studies for
movement between different GC (Zheng et al., 1996).
The function of GC Tfh cells has been more difficult to ascer-
tain. Interfering with CD28-CD86 or CD40-CD40L interactions
leads to dissolution of established GC (Han et al., 1995). With
high frequencies of high-affinity BCR, transgenic B cells and
multivalent forms of antigen can promote GC formation without
Th cells and in the absence of CD40 or CD28 signals (de Vinuesa
et al., 2000). Th cell-independent GCs are histologically similar
to typical Th cell-regulated GCs, containing immune complexes,
FDC, and B cells with a GC phenotype (Gaspal et al., 2006) but
dissimilar global gene expression patterns. Importantly, TI GCs
collapse early after priming with no evidence for somatic diver-
sification of the BCR (de Vinuesa et al., 2000; Gaspal et al.,
2006; Toellner et al., 2002). Thus, the presence of GC Tfh cells
does not appear to be necessary for the generation of GC
microenvironments but they appear important for the later
events of GC B cell selection and the production of high-affinity
B cell memory.
GC Cellular Dynamics
Recent dynamic imaging of the GC reaction in situ has provided
outstanding clarity to the kinetics of GC B cell (Hauser et al.,
2007; Schwickert et al., 2007) and GC Tfh cell movements and
interactions (Allen et al., 2007b). There was evidence for inter-
zonal movement of GC B cells indicating bidirectional migration
between light and dark zones (Allen et al., 2007b; Hauser et al.,
2007; Schwickert et al., 2007), with one study emphasizing the
majority of movement to be intrazonal (Hauser et al., 2007).
Surprisingly, cell division appeared in both zones of the GC incontrast to classical models (Allen et al., 2007b; Hauser et al.,
2007; Schwickert et al., 2007). There was also evidence for the
ability of naive B cells to traverse the GC environment with
evidence that high-affinity B cells could also enter and dominate
existing GCs (Schwickert et al., 2007). All studies identified highly
motile GC B cell movements with evidence for continuous
uninterrupted movement over FDC processes. This movement
contrasted with the capacity of GC B cells to form frequent
short-term contacts but infrequent stable contacts with GC Tfh
cells (Allen et al., 2007b). The latter group suggested that these
infrequent cognate contacts play a dominant role in the selection
of high-affinity BCR-expressing GC B cells (Allen et al., 2007a).
Hence, a unique model for affinity-based selection emerges
with uninterrupted access of GC B cells to antigen-coated
FDC followed by the ability of ‘‘reprimed’’ B cells to express
pMHCII complexes to amounts that gain competitive access to
pMHCII-specific GC Tfh cells.
It is important to emphasize that the functions of the pMHCII-
specificGCTfh cells appear broadly distinct from the effector Tfh
cell counterparts. First, entry of Tfh cells into the GC environment
appears dependent on prior interactions with pre-GC B cells (Qi
et al., 2008). Entry of effector Tfh cells into the GCmay not be the
only pathway of GC entry, but appears to be one method of
gaining access into this microenvironment. Extensive clonal
expansion ensues for the B cells within the GC environment
(MacLennan, 1994) and therefore precludes continued contact
with the effector Tfh cells at the time point of entry. Furthermore,
it is unclear whether there are developmental changes that occur
within the effector Tfh cells between the point of entry and the
capacity to form stable contacts with GCB cells after BCR diver-
sification. Controlling GC B cell exit and the development of
high-affinity B cell memory is also correlated with the presence
of GC Tfh cells (Toellner et al., 2002). It is possible that the GC
Tfh cells promote and support antibody isotype switch within
the GC. However, it is also likely that commitment to isotype
switch has already occurred and does not require these
secondary contact events as discussed above. Alternatively,
there may exist subsets of GC Tfh cells specialized to select
and support GCB cells of particular isotypes.Within this context,
the major differential outcome of the GC interaction would be
amajor division represented by entry into the ‘‘reactive’’ memory
B cell compartment or entry into long-lived plasma cell pathway
(depicted in Figure 3). Both pathways contribute to long-term
immune protection and represent two broad layers of antigen-
specific B cell memory.
Memory Tfh cells
The original CXCR5+ Tfh cells were identified in human periph-
eral blood as circulating subpopulations of resting Th cells with
a memory phenotype (Forster et al., 1994). Functional analysis
of these circulating Tfh cells distinguishes their activity from
tonsillar Tfh cells with reduced capacity for promoting antibody
production by B cells (Kim et al., 2001). Nevertheless, the circu-
lating Tfh cell compartment may play a differential role in the
regulation of memory B cells compared with the other Th cell
memory compartment (Sallusto et al., 2004). The organization
of antigen-specific memory Tfh cells and the regulation of
memory B cell responses is an important but poorly studied facet
of this research area.Immunity 30, March 20, 2009 ª2009 Elsevier Inc. 331
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presence of a CXCR5+ Tfh cell compartment that remained resi-
dent within the LNs and had decreased expression of ICOS and
cytokinemRNA in vivo but rapid and differential induction of IL-4,
IL-10, and IL-21 upon restimulation with antigen in vitro (Fazilleau
et al., 2007a). We proposed that these cells were the memory
counterpart of the effector Tfh cell population that emerged after
initial priming. We provided evidence that local memory B cell
responses arose more rapidly in their presence than elsewhere
after antigen rechallenge. The continued expression of CD69
on the memory Tfh cell compartment suggested recent TCR
triggering with pMHCII complexes. Adoptive transfer of naive
TCR transgenic Th cells located pMHCII depots in the draining
LNs and not in the nondraining LNs or the spleen of previously
immunized mice (Fazilleau et al., 2007a). These data suggested
the presence of a resident B zone-localized memory Tfh cell
compartment able to rapidly regulate pMHCII-expressing
memory B cells upon rechallenge with antigen. We predict that
cognate interactions that define the regulation of memory B cells
(checkpoint IV) would be qualitatively and quantitatively distinct
from the interactions that define cell fate after initial priming.
Understanding and then controlling these molecular interactions
will provide new impetus and novel targets for the basic strate-
gies used in typical prime-boost vaccines regimes.
Conclusions
Tfh cells are a class of regulatory Th cells that specialize in the
cognate control of antigen-specific B cell immunity. Upon
antigen-specific activation, the emergence and movement of
CXCR5+CCR7lo pMHCII-specific Tfh cells into the follicular
regions is the major attribute of Tfh cells. These Tfh cells express
CD40L, ICOS, and SAP to form stable contacts with antigen-
primed B cells with evidence for IL-4, IFN-g, IL-10, and IL-21
as soluble factors to modify B cell fate. Distinct control of IL-21
production and the expression of Bcl-6 help to distinguish Tfh
cells from other polarized T helper cell subsets and may define
a separable Th cell lineage. However, we favor a model in which
all known Th cell lineages can be deployed to the follicular
regions to regulate a spectrum of outcomes in B cell immunity.
In this model, both lineage and location would define the regula-
tory function of pMHCII-specific Tfh cells.
There are three major junctures in the delivery of cognate Tfh
cell function in vivo. After T helper clonal selection and differen-
tiation of effector function, first contact with antigen-primed
B cells occurs pre-GC in the follicular regions. We propose
that these effector Tfh cells control commitment to antibody
isotype and entry into short-lived PC versus GC pathway to
memory. Entry into the GC defines a distinct compartment of
GC Tfh cells that control GC B cell selection and survival and
entry into the long-lived memory B cell and PC compartments.
Long-term persistence in LNs defines a separate restingmemory
Tfh cell compartment that control memory B cell expansion and
rapid PC differentiation upon antigen rechallenge in vivo. Under-
standing the cellular development and molecular control of
antigen-specific B cell immunity will provide new targets for
the immunotherapeutic management of many clinical diseases
with the potential to change the basic design of future vaccine
strategies.332 Immunity 30, March 20, 2009 ª2009 Elsevier Inc.ACKNOWLEDGMENTS
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